Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAP4K1 | Q92918 | 1/20 | 0.60 |
| ▸ | ABL1 | P00519 | 1/20 | 0.58 |
| ▸ | CAMKK2 | Q96RR4 | 6/20 | 0.50 |
| ▸ | AAK1 | Q2M2I8 | 2/20 | 0.50 |
| ▸ | KIT | P10721 | 2/20 | 0.50 |
| ▸ | MAP3K11 | Q16584 | 1/20 | 0.49 |
| ▸ | SGK1 | O00141 | 2/20 | 0.48 |
| ▸ | AXL | P30530 | 4/20 | 0.48 |
| ▸ | NEK1 | Q96PY6 | 1/20 | 0.48 |
| ▸ | RIPK1 | Q13546 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13342256 | 0.90 | MAP4K1 (0.72) | MAP4K1ABL1CAMKK2AAK1KIT | |
| SCHEMBL13342249 | 0.85 | KIT (0.58) | MAP4K1ABL1CAMKK2KITMAP3K11 | |
| SCHEMBL3488761 | 0.84 | AKR1C2 (0.45) | MAP4K1ABL1AAK1AXL | |
| SCHEMBL12762899 | 0.82 | MAP4K1 (0.60) | MAP4K1ABL1AAK1KIT | |
| SCHEMBL13342206 | 0.82 | MAP4K1 (0.76) | MAP4K1ABL1CAMKK2AAK1KIT | |
| SCHEMBL14413466 | 0.82 | MAP4K1 (0.53) | MAP4K1ABL1CAMKK2AAK1KIT | |
| SCHEMBL13342241 | 0.81 | MAP4K1 (0.52) | MAP4K1ABL1CAMKK2KITMAP3K11 | |
| SCHEMBL13342276 | 0.81 | MAP4K1 (0.52) | MAP4K1ABL1CAMKK2KITMAP3K11 | |
| SCHEMBL13342280 | 0.81 | MAP4K1 (0.52) | MAP4K1ABL1CAMKK2KITMAP3K11 | |
| SCHEMBL3568852 | 0.80 | MAP4K1 (0.51) | MAP4K1ABL1CAMKK2KITMAP3K11 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7709645-B2 | Pyrrolo-pyridine kinase modulators | SGX PHARMACEUTICALS, INC. (US) | 2010-05-04 | — | — | US | disclosed |
| US-7709645-B2 | Pyrrolo-pyridine kinase modulators | SGX PHARMACEUTICALS, INC. (US) | 2010-05-04 | — | — | US | disclosed |
| US-7709645-B2 | Pyrrolo-pyridine kinase modulators | SGX PHARMACEUTICALS, INC. (US) | 2010-05-04 | — | — | US | disclosed |
| EP-2134343-A2 | PYRROLO-PYRIDINE KINASE MODULATORS | SGX Pharmaceuticals, Inc. (US) | 2009-12-23 | — | — | EP | disclosed |
| US-20090143352-A1 | PYRROLO-PYRIDINE KINASE MODULATIORS | SGX PHARMACEUTICALS, INC. (US) | 2009-06-04 | — | — | US | disclosed |
| US-20090143352-A1 | PYRROLO-PYRIDINE KINASE MODULATIORS | SGX PHARMACEUTICALS, INC. (US) | 2009-06-04 | — | — | US | disclosed |
| US-20090143352-A1 | PYRROLO-PYRIDINE KINASE MODULATIORS | SGX PHARMACEUTICALS, INC. (US) | 2009-06-04 | — | — | US | disclosed |
| WO-2008124849-A2 | PYRROLO-PYRIDINE KINASE MODULATORS | SGX PHARMACEUTICALS, INC. (US) | 2008-10-16 | — | — | WO | disclosed |
| WO-2008124849-A2 | PYRROLO-PYRIDINE KINASE MODULATORS | SGX PHARMACEUTICALS, INC. (US) | 2008-10-16 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090143352-A1 | PYRROLO-PYRIDINE KINASE MODULATIORS | MAP4K2, PDXK, MAP4K1 | MAP4K1 3/4885ABL1 348/4885CAMKK2 37/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.